Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
On September 1, 2026, AnaptysBio, Inc. revealed that Chris Murphy, their CFO, will be speaking at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. AnaptysBio primarily manages financial partnerships for Jemperli with GSK and imsidolimab with Vanda. The presentation is set to commence at 3:30pm ET. This company, listed on the Nasdaq as ANAB, focuses on collaborations in the pharmaceutical industry.